On this page
Study tools
Write your answer
Saved on this device. No marking — you are the marker.
Stem
A 23-year-old woman is brought to the emergency department by her partner, having become confused and short of breath over the previous 12 hours. She is menstruating (day 2) and uses tampons. She complained earlier of fever, severe muscle aches, a sore throat, and several episodes of vomiting and diarrhoea. On examination she is drowsy (GCS 13), temperature 39.4 deg C, pulse 128/min, blood pressure 78/44 mmHg, respiratory rate 30/min, oxygen saturation 91 percent on air. She has a diffuse, non-pruritic, blanching 'sunburn-like' macular erythema over her trunk, face, palms and soles. Her conjunctivae and oropharyngeal mucosa are intensely hyperaemic with a 'strawberry tongue'; there is a foul-smelling vaginal discharge and a retained tampon string is visible.
Investigations: haemoglobin 118 g/L, white cell count 24.6 x10^9/L (neutrophilia), platelets 74 x10^9/L. Sodium 132 mmol/L, potassium 4.8 mmol/L, creatinine 196 micromol/L (baseline 70). Total bilirubin 48 micromol/L, AST 165 U/L, ALT 142 U/L. Creatine kinase 2400 U/L. INR 1.8, fibrinogen 1.4 g/L, D-dimer markedly raised. Lactate 4.8 mmol/L. Two sets of blood cultures are sent.
Questions
a) What is the diagnosis, and state the cardinal clinical tetrad. (2 marks)
Diagnosis: staphylococcal toxic shock syndrome (menstrual) — an acute, toxin-mediated (superantigen) multisystem illness caused by TSST-1-producing Staphylococcus aureus.
The cardinal tetrad is: (1) fever over 38.9 deg C; (2) diffuse blanching macular 'sunburn-like' rash; (3) hypotension (systolic 78 mmHg here); (4) multi-organ involvement (here GI vomiting/diarrhoea, muscular myalgia with CPK over 2x ULN, mucous membrane hyperaemia, renal creatinine over 2x ULN, hepatic AST/ALT/bilirubin over 2x ULN, haematologic platelets under 100,000, CNS disorientation — well over the CDC threshold of 3 systems). The retained tampon is the source.
b) Explain the molecular mechanism by which the toxin produces this syndrome. (3 marks)
TSST-1 is a bacterial superantigen. In normal antigen presentation the antigen-presenting cell (APC) processes antigen into peptide fragments, loads them into the groove of MHC class II, and only T-cells whose TCR CDR3 region specifically recognises that peptide-MHC complex are activated (~0.01 percent, 1 in 10,000 T-cells).
TSST-1 bypasses this specificity: it binds DIRECTLY to the OUTER side surface of MHC class II (NOT in the peptide groove) AND simultaneously to the OUTER surface of the T-cell receptor beta-chain variable (V-beta) region (NOT the antigen-specific CDR3). This bridges the APC and T-cell without antigen processing or specificity, activating 20 to 30 percent of ALL T-cells simultaneously (a 1,000- to 10,000-fold increase).
The resulting polyclonal T-cell activation generates a massive cytokine storm — IL-1, IL-2, TNF-alpha, IFN-gamma — which are the direct mediators of capillary leak (rash, oedema, hypotension), systemic vasodilation (refractory hypotension), myocardial depression and multi-organ failure. The syndrome is mediated ENTIRELY by host cytokines — which is why staphylococcal TSS is typically NOT bacteraemic (blood cultures negative) and why organism isolation is NOT required for the CDC diagnosis.
c) Outline the stepwise management, with drug doses and the single most important immediate action. (4 marks)
- REMOVE THE TAMPON IMMEDIATELY — the single most important first action; this alone can abort the syndrome. Send the tampon and a vaginal swab for culture.
- ABCDE resuscitation — high-flow oxygen; two large-bore IV cannulae; aggressive IV crystalloid 10 to 20 mL/kg boluses repeated (titrated to MAP at least 65 mmHg, urine output at least 0.5 mL/kg/h, lactate clearance — severe capillary leak means very large volumes may be needed).
- Vasopressors for refractory shock — noradrenaline (norepinephrine) titrated to MAP at least 65 mmHg; do not delay while giving more fluids if shock is refractory.
- Empirical IV antibiotics WITHIN 1 HOUR, covering both staph (incl. MRSA) and strep AND suppressing toxin: clindamycin 600 to 900 mg IV q8h (the anti-toxin — suppresses TSST-1 synthesis) PLUS flucloxacillin 2 g IV q6h (MSSA) PLUS vancomycin 15 to 20 mg/kg IV q8 to 12h (MRSA cover) PLUS benzylpenicillin 2.4 g IV q4 to 6h (GAS).
- IVIG 1 to 2 g/kg IV single infusion for severe / refractory disease — provides anti-TSST-1 antibodies and neutralises circulating superantigen.
- ICU admission for organ support: mechanical ventilation for respiratory failure/ARDS, renal replacement therapy for her AKI, management of DIC (transfuse platelets/plasma if bleeding), VTE prophylaxis.
d) State ONE antibiotic you must ADD to a beta-lactam and explain WHY. Name the drug-exam trap. (1 mark)
Clindamycin — the cornerstone anti-toxin. It inhibits the 50S ribosomal subunit and suppresses TSST-1 (and Spe) protein synthesis by about 90 percent, even when organisms are viable. The trap: penicillin/oxacillin ALONE may transiently INCREASE toxin release by lysing bacteria, so a beta-lactam must ALWAYS be combined with clindamycin. Clindamycin is also unaffected by the 'Eagle effect' that limits penicillin in high-inoculum stationary-phase GAS infection.